SWI swissinfo.ch: Swiss pharma suspected of delaying generic competition

Front page - SWI swissinfo.ch

Drug companies
Swiss pharma suspected of delaying generic competition

    Business

 See in another language: 1
This content was published on May 17, 2018 5:54 PM May 17, 2018 - 17:54
A gloved hand using an instrument to separate blue pills

Switzerland is home to a thriving pharmaceutical industry.
(Keystone)


The United States Food and Drug Administration (FDA) published Thursday a list of pharmaceutical companies that include Basel-based Novartis and Roche, all of which are suspected of hindering the development of generic versions of their own medicines. Over 150 complaints were filed.

The FDA slammed the development of techniques designed to complicate or even prevent developers of generic drugs from accessing sufficient quantities of original preparations to be able to do comparative studies essential to any application for approval.

The authority said it has received more than 150 complaints over the alleged misuse of FDA programmes or agreements between pharmaceutical companies and distributors.

The FDA noted that it had not investigated these allegations.

SDA-ATS/ds

Neuer Inhalt

Horizontal Line
swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!
subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.
Email address
Top stories (weekly)
Latest news (daily)
Business (weekly)
Politics (weekly)
Society (weekly)
Fintech (monthly)

Click here to see more newsletters
Comment on this article:

Related Stories
Le directeur de Novartis Joe Jimenez devant la Maison-Blanche
Trumping Trump?
Swiss multinationals step up US lobbying
By Alexis Rapin

Swiss multinationals in the United States spent nearly CHF22 million on lobbying last year.

    Business

See in other languages: 5
Ein kambodschanischer Junge lächelt in die Kamera
World Malaria Day
Switzerland’s global role in fighting malaria

Each year, some half a million people die of malaria, many of them children. Switzerland is a world leader in research to combat the disease.

    Politics
    Sci & Tech
    Health

See in other languages: 3
A Norwegian soldier involved in the removal of the chemical stockpile from Syria in 2014
For sarin gas?
Swiss authorities allowed isopropanol exports to Syria

Switzerland authorised the export to Syria of the chemical isopropanol in 2014, which can be used to make sarin gas, RTS, reports.
2 There are 2 comments on this article.

    Business
    Politics

See in other languages: 3
building
Pharmaceuticals
Novartis and GSK CEOs set out diverging strategies
By Sarah Neville, Ralph Atkins and Arash Massoudi

It is a tale of two newly minted chief executives, each looking to send a clear signal to investors about strategy and priorities.
1 There is one comment on this article.

    Business

Footer

    The company | Partnerships | Imprint | Jobs | Play SWI | Newsletter subscription | Contact

Back to top
World partners:

    Radio Netherlands Worldwide | Radio Canada International | Radio Praha | Polskie Radio

    RTS | SRF | RSI | RTR | SWI

Front page - SWI swissinfo.ch
swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR